Self and Body Perception in Otoneurological Disorders: Translation and Validation of Measurement Scales
PERSOCOR
Other study identifiers
Sponsor study identifier
interventional
612
1 country
1
Study Start
March 31, 2022
Actual (reported)Primary Completion
October 3, 2024
Actual (reported)Study Completion
October 3, 2024
Actual (reported)Brief Summary
Depersonalization-derealization (DD) disorders are a clinical phenomenon characterized by feeling disconnected or detached from one's self. Individuals may report feeling as if they are an outside observer of their own thoughts or body, and often report feeling a loss of control over their thoughts or actions. Several scales have been developed to measure DD, and the Cambridge Depersonalization Scale (CDS) appears to be the most relevant and consistent to characterize the clinical symptoms of these disorders as well as their duration and frequency. This scale, originally written in English, must be translated and validated according to standardized methods that include testing steps patients with dizziness and in individuals with no vestibular disorder. Persistent postural-perceptual dizziness (PPPD) is a chronic, persistent vestibular syndrome generally preceded by acute vestibular disorders. The main symptoms are rotational dizziness, unsteadiness and / or non-rotating dizziness that are exacerbated by upright posture, walking, active or passive movement, and exposure to moving visual stimuli or complex visual patterns. To help diagnose this syndrome, a questionnaire was developed in Japan in 2019, the Niigata questionnaire, however no French version has yet been validated. Similarly, this scale needs to be validated in patient with PPPD and in control populations. The main objective of this study is to validate the French translation of these two scales, the CDS questionnaire and the Niigata PPPD questionnaire, according to standard methods (forward translation, back translation, consensus).
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
- Recruitment status
- completed
- Actual enrollment (reported)
- 612 participants
- Study completion date
October 3, 2024
Actual (reported)- Listed locations
- 1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
First Submitted
January 18, 2022
Actual (reported)First Posted
February 21, 2022
Actual (reported)Study Start
March 31, 2022
Actual (reported)Primary Completion
October 3, 2024
Actual (reported)Study Completion
October 3, 2024
Actual (reported)
- Last Updated
- October 28, 2026
- Status Verified
- September 2025
- Last Update Submitted
- October 26, 2026